NCT03313401View on ClinicalTrials.gov

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Aflibercept

Intravitreal aflibercept injection

DEVICE

Specular microscopy

Specular microscopy measurement after intravitreal aflibercept injection

All Listed Sponsors
lead

Ulucanlar Eye Training and Research Hospital

OTHER

NCT03313401 - Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter